September 28th is National Women’s Health and Fitness Day and women
are encouraged to take control of their health
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Arizona
Oncology, one of the largest medical groups in Arizona devoted to
cancer care and a practice in The
US Oncology Network, is the first in Arizona to utilize the latest
technology and advancement in the early detection of cervical cancer and
pre-cancers. The practice has implemented the DYSIS® Advanced
Cervical Imaging System. This advanced digital colposcope, an instrument
for examining the cervix, has computer-aided mapping technology and can
enhance a doctor’s ability to diagnose and manage cervical neoplasia,
precancerous cells, by detecting changes in a woman’s cervix after an
abnormal Pap smear.
More than 12,000 women are diagnosed with cervical cancer each year in
the U.S., and many of those women will be among the thousands
participating in local health and fitness events across the country on
Wednesday, September 28th. One goal of the National Women’s
Health and Fitness Day is to encourage women to take control of their
health and to gather information to help them make smart choices related
to their health. Arizona Oncology adopted the DYSIS colposcope
technology to not only assist physicians in identifying pre-cancerous or
cancerous cells on the cervix, but to also help women understand their
colposcopy exam through high-resolution imagery and easy-to-read
color-coded maps of the cervix provided by DYSIS technology.
“The new DYSIS technology helps us better pinpoint questionable areas on
the cervix that may need biopsy,” said Dr.
Mike Janicek, gynecologic oncologist at Arizona Oncology. “We can
share images and the color-coded maps with women in real time
immediately following the exam. We can provide color digital or paper
copies of the exam images for patients and their referring providers.
Our goal is have our patients feel reassured and involved in their
healthcare when having a DYSIS colposcopy exam, and referring doctors
can feel more involved in the evaluation process as well.”
Colposcopy, which can be subjective and has remained unchanged for
decades, is an exam performed after a woman has an abnormal Pap smear.
DYSIS has advanced the standard colposcopy technique by using digital
imaging technology that assists physicians in detecting changes in a
woman’s cervix and helping guide biopsy selection to determine the best
course of treatment to prevent cervical cancer.
“We are excited to be working with Arizona Oncology, a distinguished
oncology specialty group that recognizes the importance of advancing
today’s cervical screening technology,” said Kim Stebbings, U.S.
president of DYSIS Medical. “By standardizing the currently subjective
colposcopy procedure, we can help improve care for women and help them
take control of their health.”
About Arizona Oncology
Arizona Oncology is one of the largest medical groups in Arizona. With
more than 75 practicing physicians devoted exclusively to providing
comprehensive, compassionate and high-quality cancer care, Arizona
Oncology specializes in Medical, Gynecologic, and Radiation Oncology,
Hematology, Stem Cell Transplant, Research, Genetic Risk Assessment and
patient ancillary programs. The physicians and their staff treat
patients in many communities throughout the state including: Chandler,
Deer Valley, Estrella, Flagstaff, Glendale, Green Valley, Nogales,
Peoria, Phoenix, Prescott Valley, Safford, Scottsdale, Sedona, and
Arizona Oncology believes it is beneficial to provide cancer therapies
in a community setting, close to patients’ homes and support systems.
The physicians are supported by a talented clinical team sensitive to
the needs of cancer patients and their caregivers. For more information,
Arizona Oncology is united in healing with The US Oncology Network, one
of the nation’s largest networks of integrated community-based oncology
practices dedicated to advancing high-quality, evidence-based cancer
care. As an affiliate of The US Oncology Network, Arizona Oncology is
united with more than 1,000 physicians nationwide. Arizona Oncology
participates in clinical trials through US
Oncology Research, which has played a role in more than 60
FDA-approved cancer therapies, nearly one-third of all cancer therapies
approved by the FDA to date. For more information, visit www.usoncology.com.
About DYSIS Medical
DYSIS Medical has its global headquarters in Edinburgh and US
Headquarters in Tampa, FL. The company is committed to saving lives
through the early detection and diagnosis of disease using biophotonic
innovations. It aims to be the global leader in automated optical
molecular imaging technologies for medical diagnostic and screening
applications. For more information, please visit: www.abnormalpapsmear.com
or call 844-DYSISMED.
About the DYSIS colposcope
The DYSIS colposcope differs from traditional colposcopes by measuring
the cervical epithelium automatically using Dynamic Spectral Imaging and
producing a map of the cervix, which assists the clinician with
assessing the cervix, identifying biopsy locations and performing
treatment if needed.
About cervical cancer
Worldwide, cervical cancer is the fourth most common cancer for women
and the seventh most common cancer overall. While it is the only
entirely preventable cancer, approximately half a million women are
diagnosed with the disease every year.
The US Oncology Network
Amy Robertson, 480-789-2986